EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Rebound Hypoxemia in Mechanically Ventilated Patients With COVID-19 Completing a Standard 10-Day Course of Corticosteroid Therapy

Rahul Costa-Pinto, Hannah Rotherham, Zachary O'Brien, Padeepa Perera, Vicky Chen, Christopher Massarany, Brett Xu, Rinaldo Bellomo

Respiratory Care · 2025

DOI: 10.1089/respcare.12494 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Respiratory Care, 2025. Verfasst von Rahul Costa-Pinto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Drs. Costa-Pinto, Massarany, Xu and Prof. Bellomo are affiliated with Department of Intensive Care, Austin Hospital, Heidelberg, Victoria, Australia. Hauptthemen laut MEDLINE: Adrenal Cortex Hormones, COVID-19, COVID-19 Drug Treatment, Dexamethasone. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rebound hypoxemia may occur after cessation of corticosteroid therapy for COVID-19 pneumonitis. We aimed to determine the incidence of this phenomenon in mechanically ventilated patients with COVID-19 completing corticosteroid therapy.

Methods

We conducted a retrospective observational cohort study across 2 tertiary ICUs from September to December 2021. We included all adult patients receiving invasive mechanical ventilation on completion of a 10-day course of dexamethasone for COVID pneumonitis. Our primary outcome was change in PaO2/FIO2 ratio in the 7 days following cessation of dexamethasone. Secondary outcomes included duration of ventilation, frequency of corticosteroid recommencement, and mortality.

Results

We studied 88 subjects. Median age was 61 years (interquartile range [IQR] 51-67), and median duration of mechanical ventilation was 14 days (IQR 11-26). On completion of dexamethasone, 62 subjects (70%) remained off corticosteroid therapy for the subsequent 7 days. Of these, 63% (n = 20) had a stable PaO2/FIO2 ratio on day 7 (mean change 197 ± 42 mm Hg to 258 ± 83 mm Hg). Subjects who had a reduction in PaO2/FIO2 ratio >20 mm Hg by day 7 (mean change 214 ± 68 mm Hg to 152 ± 78 mm Hg) were more likely to die in hospital (P < .001). These subjects had a higher C-reactive protein level at time of steroid cessation (204 ± 87 mg/L, P = .17), which remained persistently elevated (206 ± 89 mg/L, P = .01) on day 7. The 30% of subjects who recommenced steroids required a longer duration of ventilation (13.5 vs 24.5 d, P = .002) but showed no differences in ICU mortality (19% vs 27%, P = .43).

Conclusions

Rebound hypoxemia and steroid recommencement were common occurrences in mechanically ventilated subjects with COVID-19. Rebound hypoxemia was associated with higher mortality. Steroid recommencement was associated with longer duration of mechanical ventilation but no significant difference in mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal Cortex HormonesCOVID-19COVID-19 Drug TreatmentDexamethasoneGlucocorticoidsHypoxiaRespiration, ArtificialAgedFemaleHumansMaleMiddle AgedIntensive Care UnitsRetrospective StudiesSARS-CoV-2Cohort Studies

Stichwörter der Autor:innen

COVID-19corticosteroidsdexamethasonemechanical ventilationorganizing pneumoniarebound hypoxemia

Substanzen

Adrenal Cortex HormonesDexamethasoneGlucocorticoids

Autor:innen und Institutionen

  • Drs. Costa-Pinto, Massarany, Xu and Prof. Bellomo are affiliated with Department of Intensive Care, Austin Hospital, Heidelberg, Victoria, Australia.
  • Drs. Costa-Pinto, Rotherham and Prof. Bellomo are affiliated with Department of Critical Care, Department of Medicine, the University of Melbourne, Parkville, Victoria, Australia.
  • Drs. Rotherham, Perera, Chen and Prof. Bellomo are affiliated with Department of Intensive Care, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Dr. O'Brien is affiliated with Department of Anaesthesia, Austin Hospital, Heidelberg, Victoria, Australia.
  • Prof. Bellomo is affiliated with Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Prof. Bellomo was affiliated with Data Analytics Research and Evaluation Centre, The University of Melbourne and Austin Hospital, Melbourne, Australia.

Zitieren

APA

Costa-Pinto, R., Rotherham, H., O'Brien, Z., Perera, P., Chen, V., Massarany, C., Xu, B., & Bellomo, R. (2025). Rebound Hypoxemia in Mechanically Ventilated Patients With COVID-19 Completing a Standard 10-Day Course of Corticosteroid Therapy. Respiratory Care. https://doi.org/10.1089/respcare.12494

Vancouver

Costa-Pinto R, Rotherham H, O'Brien Z, Perera P, Chen V, Massarany C, et al. Rebound Hypoxemia in Mechanically Ventilated Patients With COVID-19 Completing a Standard 10-Day Course of Corticosteroid Therapy. Respiratory Care. 2025. doi:10.1089/respcare.12494

BibTeX
@article{CostaPinto2025,
  author = {Costa-Pinto, Rahul and Rotherham, Hannah and O'Brien, Zachary and Perera, Padeepa and Chen, Vicky and Massarany, Christopher and Xu, Brett and Bellomo, Rinaldo},
  title = {Rebound Hypoxemia in Mechanically Ventilated Patients With COVID-19 Completing a Standard 10-Day Course of Corticosteroid Therapy},
  journal = {Respiratory Care},
  year = {2025},
  doi = {10.1089/respcare.12494}
}
Kostenlos starten →